Iowa State University
INDEX A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Service

News Service:

Annette Hacker, director,
(515) 294-3720

Office: (515) 294-4777

10-28-08

Contacts:

Sinisa Grozdanic, Veterinary Clinical Sciences, (515) 294- 4900, sgrozdan@iastate.edu

Tom Ligouri, College of Veterinary Medicine, (515) 294-4257, ligouri@iastate.edu

Dan Kuester, News Service, (515) 294-0704, kuester@iastate.edu

Photos: Iowa State researcher develops new treatment method for canine eye diseases

Eye procedure

Left photo shows Gora's eye before tacrolimus implant placement. Eye is hazy and dark due to pigment and blood vessel infiltration as a result of the auto-immune corneal disease. Gora's sight was progressively failing despite medical therapy over the period of two years.

Right photo shows Gora's eye 4 weeks after surgical placement of drug eluting implant. Haziness, blood vessels and pigment significantly regressed, and Gora was able to go back to full active duty due to significant improvement in vision.

Eye surgery results

Patient (not Gora) treated at ISU with tacrolimus implant procedure. Arrow points to the region where implant was surgically placed in the tissue. This patient had severe ocular changes due to auto-immune disease non-responsive to any medical treatment. Surgical implant procedure resulted in significant clearing of eye and vision improvement only 3 weeks after procedure.

Eye transplant

Tacrolimus implant was developed as a result of collaborative work between ISU scientists and NICAST Ltd. (Israel-based biotechnology company).

-30-